Genetic
niPGT-A
niPGT-A is a genetic therapy with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Recruiting1
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
recruiting120%
completed240%
terminated120%
unknown120%
Recent Activity
1 active trials
Showing 5 of 5
completed
Correlation of the Genetic Constitution of the Spent Blastocyst Media
NCT06780605
terminatednot_applicable
RCT Study to Validate niPGT-A Clinical Benefit.
NCT04000152
recruiting
International Pilot Study for Dual Non-invasive Assesment of Embryo Development
NCT06524648
completed
Multi-center Study to Validate niPGT-A
NCT03520933
unknown
Noninvasive Preimplantation Genetic Testing for Aneuploidy
NCT04490889
Clinical Trials (5)
Showing 5 of 5 trials
NCT06780605
Correlation of the Genetic Constitution of the Spent Blastocyst Media
NCT04000152Not Applicable
RCT Study to Validate niPGT-A Clinical Benefit.
NCT06524648
International Pilot Study for Dual Non-invasive Assesment of Embryo Development
NCT03520933
Multi-center Study to Validate niPGT-A
NCT04490889
Noninvasive Preimplantation Genetic Testing for Aneuploidy
All 5 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 5